Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
Active, not recruiting · NCT06101329 · Registry updated 2026-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) | Pre-Exposure Prophylaxis of HIV Infection | Active, not recruiting | Phase 2 | 2026-08-17 | NCT06101329 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
| HIV Prevention Trials Network | 6 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cornell Clinical Trials Unit, New York Presbyterian Hospital - Weill Cornell Medicine | New York | United States | 1 |
| Fenway Health | Boston | United States | 8 |
| George Washington University Medical Faculty Associates | Washington D.C. | United States | 6 |
| Harlem Prevention Center CRS | New York | United States | 1 |
| ICAP at Columbia University - Bronx Prevention Center | The Bronx | United States | 1 |
| NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill | Chapel Hill | United States | 1 |
| Penn Prevention Research Unit | Philadelphia | United States | 1 |
| Rutgers New Jesey Medical School - Clinical Research Center | Newark | United States | 1 |
| UAB, 1917 Research Clinic | Birmingham | United States | 1 |
| UCSD AntiViral Research Center (AVRC) | San Diego | United States | 3 |